298 related articles for article (PubMed ID: 3486042)
21. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Tetsuka T; Motoyoshi K; Miura Y; Saito M
Blood; 1984 Aug; 64(2):534-41. PubMed ID: 6589019
[TBL] [Abstract][Full Text] [Related]
22. Modulation of complement receptors of a human monocyte cell line, U-937, during incubation with phorbol myristate acetate: expression of an iC3b-specific receptor (CR3).
Gilbert D; Peulve P; Daveau M; Ripoche J; Fontaine M
Eur J Immunol; 1985 Oct; 15(10):986-91. PubMed ID: 2932340
[TBL] [Abstract][Full Text] [Related]
23. Polyadenylic acid metabolizing enzyme levels during induction of differentiation in a human leukemia T-cell line with phorbol ester.
Perez S; Trangas T; Kokkinopoulos D; Tsiapalis CM; Papamichail M
J Natl Cancer Inst; 1987 Mar; 78(3):407-11. PubMed ID: 3029496
[TBL] [Abstract][Full Text] [Related]
24. Effect of a cell differentiation inducer, ganglioside GM3, on the neutral glycosphingolipid composition and cell membrane fluidity of a human promyelocytic leukemia cell line HL-60.
Tsui ZC; Hou WH; Yang L; Zhu ZM
In Vivo; 1990; 4(3):205-8. PubMed ID: 2133263
[TBL] [Abstract][Full Text] [Related]
25. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of ganglioside and asialoglycosphingolipid antigens in adult T-cell leukemia cells.
Suzuki Y; Hirabayashi Y; Matsumoto N; Kato H; Hidari K; Tsuchiya K; Matsumoto M; Hoshino H; Tozawa H; Miwa M
Jpn J Cancer Res; 1987 Oct; 78(10):1112-20. PubMed ID: 2890614
[TBL] [Abstract][Full Text] [Related]
27. Ceramides and glycosphingolipids in maturation process: leukemic cells as an experimental model.
Smoleńska-Sym G; Spychalska J; Zdebska E; Woźniak J; Traczyk Z; Pszenna E; Maj S; Danikiewicz W; Bieńkowski T; Kościelak J
Blood Cells Mol Dis; 2004; 33(1):68-76. PubMed ID: 15223014
[TBL] [Abstract][Full Text] [Related]
28. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
29. Mast cell heterogeneity. Differential synthesis and expression of glycosphingolipids by mouse serosal mast cells as compared to IL-3-dependent bone marrow culture-derived mast cells before or after coculture with 3T3 fibroblasts.
Raizman MB; Austen KF; Katz HR
J Immunol; 1990 Sep; 145(5):1463-8. PubMed ID: 2200824
[TBL] [Abstract][Full Text] [Related]
30. Induction of macrophage-like differentiation of HL60 human myeloid leukemia cells by phorbol myristate acetate triggers an early decline in inositol lipid breakdown.
Porfiri E; Hoffbrand AV; Wickremasinghe RG
Exp Hematol; 1989 May; 17(4):344-50. PubMed ID: 2707317
[TBL] [Abstract][Full Text] [Related]
31. In vitro induction of cytologic and functional differentiation of the immature human monocytelike cell line U-937 with phorbol myristate acetate.
Minta JO; Pambrun L
Am J Pathol; 1985 Apr; 119(1):111-26. PubMed ID: 2984940
[TBL] [Abstract][Full Text] [Related]
32. Growth and differentiation of a human T-cell leukemia cell line, CCRF-CEM, grafted in mice.
Houghton PJ; Mirro J; Goorha RM; Raimondi SC; Fridland A; Houghton JA
Cancer Res; 1989 Dec; 49(24 Pt 1):7124-31. PubMed ID: 2555061
[TBL] [Abstract][Full Text] [Related]
33. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
34. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
35. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
36. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
Nagasawa K; Howatson A; Mak TW
J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
[TBL] [Abstract][Full Text] [Related]
37. Acquisition of deoxyguanosine resistance by TPA-induced T lymphoid lines.
Sacchi N; Fiorini G; Plevani P; Badaracco G; Breviario D; Ginelli E
J Immunol; 1983 Apr; 130(4):1622-6. PubMed ID: 6601131
[TBL] [Abstract][Full Text] [Related]
38. Induction of human T-lymphocyte colonies by phorbol myristate acetate.
Suzawa T; Hyodo S; Kishi T; Kashiwa H; Kittaka E; Sakano T; Usui T
Immunology; 1983 Dec; 50(4):575-80. PubMed ID: 6606613
[TBL] [Abstract][Full Text] [Related]
39. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B
Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643
[TBL] [Abstract][Full Text] [Related]
40. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
Srinivas L; Colburn NH
Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
